nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—CYP3A4—Rifampicin—leprosy	0.0555	0.548	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Dapsone—leprosy	0.0458	0.452	CbGbCtD
Isosorbide Mononitrate—Albuminuria—Dapsone—leprosy	0.0215	0.0248	CcSEcCtD
Isosorbide Mononitrate—Hypochromic anaemia—Thalidomide—leprosy	0.0212	0.0244	CcSEcCtD
Isosorbide Mononitrate—Rales—Thalidomide—leprosy	0.0201	0.0231	CcSEcCtD
Isosorbide Mononitrate—Neck stiffness—Thalidomide—leprosy	0.0173	0.0199	CcSEcCtD
Isosorbide Mononitrate—Nuchal rigidity—Thalidomide—leprosy	0.0159	0.0182	CcSEcCtD
Isosorbide Mononitrate—Gastric ulcer—Thalidomide—leprosy	0.0142	0.0163	CcSEcCtD
Isosorbide Mononitrate—Tooth disorder—Thalidomide—leprosy	0.0127	0.0146	CcSEcCtD
Isosorbide Mononitrate—Intestinal obstruction—Thalidomide—leprosy	0.0121	0.0139	CcSEcCtD
Isosorbide Mononitrate—Hepatomegaly—Thalidomide—leprosy	0.0116	0.0134	CcSEcCtD
Isosorbide Mononitrate—Hyperlipidaemia—Thalidomide—leprosy	0.0114	0.0131	CcSEcCtD
Isosorbide Mononitrate—Albuminuria—Thalidomide—leprosy	0.011	0.0127	CcSEcCtD
Isosorbide Mononitrate—Neuritis—Thalidomide—leprosy	0.011	0.0127	CcSEcCtD
Isosorbide Mononitrate—Amblyopia—Thalidomide—leprosy	0.0107	0.0123	CcSEcCtD
Isosorbide Mononitrate—Skin ulcer—Thalidomide—leprosy	0.0106	0.0122	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Dapsone—leprosy	0.0103	0.0118	CcSEcCtD
Isosorbide Mononitrate—Acne—Thalidomide—leprosy	0.00978	0.0112	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal stiffness—Thalidomide—leprosy	0.00917	0.0105	CcSEcCtD
Isosorbide Mononitrate—Viral infection—Thalidomide—leprosy	0.00911	0.0105	CcSEcCtD
Isosorbide Mononitrate—Arthropathy—Thalidomide—leprosy	0.00905	0.0104	CcSEcCtD
Isosorbide Mononitrate—Hypocalcaemia—Thalidomide—leprosy	0.00899	0.0103	CcSEcCtD
Isosorbide Mononitrate—Hyperuricaemia—Thalidomide—leprosy	0.00887	0.0102	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Dapsone—leprosy	0.00881	0.0101	CcSEcCtD
Isosorbide Mononitrate—Leukocytosis—Thalidomide—leprosy	0.00875	0.0101	CcSEcCtD
Isosorbide Mononitrate—Hypercholesterolaemia—Thalidomide—leprosy	0.0087	0.01	CcSEcCtD
Isosorbide Mononitrate—Atrioventricular block—Thalidomide—leprosy	0.00848	0.00975	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Dapsone—leprosy	0.00843	0.0097	CcSEcCtD
Isosorbide Mononitrate—Blood uric acid increased—Thalidomide—leprosy	0.00838	0.00963	CcSEcCtD
Isosorbide Mononitrate—Coordination abnormal—Thalidomide—leprosy	0.00838	0.00963	CcSEcCtD
Isosorbide Mononitrate—Neck pain—Thalidomide—leprosy	0.00833	0.00958	CcSEcCtD
Isosorbide Mononitrate—Eructation—Thalidomide—leprosy	0.00808	0.0093	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Dapsone—leprosy	0.00801	0.00921	CcSEcCtD
Isosorbide Mononitrate—Candida infection—Thalidomide—leprosy	0.00785	0.00903	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Dapsone—leprosy	0.00752	0.00865	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Thalidomide—leprosy	0.00714	0.00821	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Thalidomide—leprosy	0.00687	0.0079	CcSEcCtD
Isosorbide Mononitrate—Vascular purpura—Thalidomide—leprosy	0.00668	0.00768	CcSEcCtD
Isosorbide Mononitrate—Eczema—Thalidomide—leprosy	0.00664	0.00764	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Dapsone—leprosy	0.00662	0.00761	CcSEcCtD
Isosorbide Mononitrate—Libido decreased—Thalidomide—leprosy	0.00644	0.00741	CcSEcCtD
Isosorbide Mononitrate—Amnesia—Thalidomide—leprosy	0.00636	0.00731	CcSEcCtD
Isosorbide Mononitrate—Increased appetite—Thalidomide—leprosy	0.00636	0.00731	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Dapsone—leprosy	0.00631	0.00726	CcSEcCtD
Isosorbide Mononitrate—Atrial fibrillation—Thalidomide—leprosy	0.0063	0.00725	CcSEcCtD
Isosorbide Mononitrate—Purpura—Thalidomide—leprosy	0.0062	0.00713	CcSEcCtD
Isosorbide Mononitrate—Arthritis—Thalidomide—leprosy	0.00614	0.00707	CcSEcCtD
Isosorbide Mononitrate—Cough—Dapsone—leprosy	0.00613	0.00705	CcSEcCtD
Isosorbide Mononitrate—Cardiac failure—Thalidomide—leprosy	0.00612	0.00704	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Thalidomide—leprosy	0.00609	0.00701	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Thalidomide—leprosy	0.00597	0.00687	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Thalidomide—leprosy	0.00597	0.00687	CcSEcCtD
Isosorbide Mononitrate—Disturbance in sexual arousal—Thalidomide—leprosy	0.00592	0.00681	CcSEcCtD
Isosorbide Mononitrate—Migraine—Thalidomide—leprosy	0.00588	0.00676	CcSEcCtD
Isosorbide Mononitrate—Affect lability—Thalidomide—leprosy	0.00588	0.00676	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Thalidomide—leprosy	0.00566	0.00651	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Dapsone—leprosy	0.0056	0.00644	CcSEcCtD
Isosorbide Mononitrate—Orthostatic hypotension—Thalidomide—leprosy	0.00545	0.00627	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Thalidomide—leprosy	0.00543	0.00625	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00538	0.00618	CcSEcCtD
Isosorbide Mononitrate—Cramp muscle—Thalidomide—leprosy	0.00538	0.00618	CcSEcCtD
Isosorbide Mononitrate—Alanine aminotransferase increased—Thalidomide—leprosy	0.00527	0.00606	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Thalidomide—leprosy	0.00527	0.00606	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Dapsone—leprosy	0.00519	0.00596	CcSEcCtD
Isosorbide Mononitrate—Bronchospasm—Thalidomide—leprosy	0.00508	0.00584	CcSEcCtD
Isosorbide Mononitrate—Angina pectoris—Thalidomide—leprosy	0.00503	0.00578	CcSEcCtD
Isosorbide Mononitrate—Bronchitis—Thalidomide—leprosy	0.00496	0.00571	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Thalidomide—leprosy	0.0048	0.00552	CcSEcCtD
Isosorbide Mononitrate—Pollakiuria—Thalidomide—leprosy	0.00477	0.00548	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Thalidomide—leprosy	0.00475	0.00547	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Thalidomide—leprosy	0.0047	0.0054	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Dapsone—leprosy	0.00469	0.00539	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Thalidomide—leprosy	0.00467	0.00537	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Thalidomide—leprosy	0.00463	0.00532	CcSEcCtD
Isosorbide Mononitrate—Acute coronary syndrome—Thalidomide—leprosy	0.00454	0.00522	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Dapsone—leprosy	0.00453	0.00521	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Dapsone—leprosy	0.00453	0.00521	CcSEcCtD
Isosorbide Mononitrate—Myocardial infarction—Thalidomide—leprosy	0.00451	0.00519	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Thalidomide—leprosy	0.00451	0.00519	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Thalidomide—leprosy	0.00447	0.00514	CcSEcCtD
Isosorbide Mononitrate—Sweating—Thalidomide—leprosy	0.00441	0.00507	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Thalidomide—leprosy	0.00439	0.00505	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Thalidomide—leprosy	0.00434	0.00499	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Thalidomide—leprosy	0.00432	0.00497	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Thalidomide—leprosy	0.00421	0.00484	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Thalidomide—leprosy	0.00414	0.00476	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Thalidomide—leprosy	0.00411	0.00473	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Thalidomide—leprosy	0.0041	0.00472	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Thalidomide—leprosy	0.00408	0.00469	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Thalidomide—leprosy	0.00407	0.00468	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Thalidomide—leprosy	0.00405	0.00466	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Thalidomide—leprosy	0.00398	0.00458	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Thalidomide—leprosy	0.00385	0.00443	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Thalidomide—leprosy	0.00383	0.00441	CcSEcCtD
Isosorbide Mononitrate—Chills—Thalidomide—leprosy	0.00371	0.00426	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Thalidomide—leprosy	0.00369	0.00424	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—tendon—leprosy	0.00366	0.125	CbGeAlD
Isosorbide Mononitrate—Vomiting—Dapsone—leprosy	0.00365	0.00419	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Thalidomide—leprosy	0.00362	0.00416	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Thalidomide—leprosy	0.0036	0.00414	CcSEcCtD
Isosorbide Mononitrate—Headache—Dapsone—leprosy	0.00359	0.00413	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Thalidomide—leprosy	0.00354	0.00408	CcSEcCtD
Isosorbide Mononitrate—Tension—Thalidomide—leprosy	0.00353	0.00406	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Thalidomide—leprosy	0.00352	0.00405	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Thalidomide—leprosy	0.00349	0.00402	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—eye—leprosy	0.00348	0.119	CbGeAlD
Isosorbide Mononitrate—Back pain—Thalidomide—leprosy	0.00348	0.004	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Thalidomide—leprosy	0.00346	0.00398	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—eye—leprosy	0.00345	0.118	CbGeAlD
Isosorbide Mononitrate—Nausea—Dapsone—leprosy	0.00341	0.00392	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Thalidomide—leprosy	0.00339	0.0039	CcSEcCtD
Isosorbide Mononitrate—Tremor—Thalidomide—leprosy	0.00337	0.00388	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Thalidomide—leprosy	0.00334	0.00384	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Thalidomide—leprosy	0.00332	0.00382	CcSEcCtD
Isosorbide Mononitrate—Agitation—Thalidomide—leprosy	0.0033	0.0038	CcSEcCtD
Isosorbide Mononitrate—Malaise—Thalidomide—leprosy	0.00324	0.00373	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Thalidomide—leprosy	0.00323	0.00372	CcSEcCtD
Isosorbide Mononitrate—Syncope—Thalidomide—leprosy	0.00322	0.00371	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Thalidomide—leprosy	0.00322	0.0037	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Thalidomide—leprosy	0.00318	0.00366	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Thalidomide—leprosy	0.00316	0.00364	CcSEcCtD
Isosorbide Mononitrate—Cough—Thalidomide—leprosy	0.00314	0.00361	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Thalidomide—leprosy	0.0031	0.00357	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Thalidomide—leprosy	0.00306	0.00352	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Thalidomide—leprosy	0.00306	0.00352	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Thalidomide—leprosy	0.00306	0.00352	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Thalidomide—leprosy	0.00305	0.00351	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—testis—leprosy	0.00303	0.104	CbGeAlD
Isosorbide Mononitrate—Discomfort—Thalidomide—leprosy	0.00302	0.00348	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Thalidomide—leprosy	0.00299	0.00344	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—nervous system—leprosy	0.00297	0.102	CbGeAlD
Isosorbide Mononitrate—Confusional state—Thalidomide—leprosy	0.00296	0.0034	CcSEcCtD
Isosorbide Mononitrate—Oedema—Thalidomide—leprosy	0.00293	0.00338	CcSEcCtD
Isosorbide Mononitrate—Infection—Thalidomide—leprosy	0.00292	0.00335	CcSEcCtD
Isosorbide Mononitrate—Shock—Thalidomide—leprosy	0.00289	0.00332	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Thalidomide—leprosy	0.00288	0.00331	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Thalidomide—leprosy	0.00287	0.00331	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Thalidomide—leprosy	0.00286	0.00329	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Thalidomide—leprosy	0.00285	0.00328	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Thalidomide—leprosy	0.00284	0.00326	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Thalidomide—leprosy	0.0028	0.00322	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Thalidomide—leprosy	0.00274	0.00315	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Thalidomide—leprosy	0.00267	0.00308	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Thalidomide—leprosy	0.00265	0.00305	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Thalidomide—leprosy	0.00264	0.00303	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Thalidomide—leprosy	0.00262	0.00301	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Thalidomide—leprosy	0.00261	0.003	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Thalidomide—leprosy	0.00258	0.00297	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Thalidomide—leprosy	0.00255	0.00293	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Thalidomide—leprosy	0.00253	0.00291	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Thalidomide—leprosy	0.00253	0.00291	CcSEcCtD
Isosorbide Mononitrate—Pain—Thalidomide—leprosy	0.00251	0.00289	CcSEcCtD
Isosorbide Mononitrate—Constipation—Thalidomide—leprosy	0.00251	0.00289	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Thalidomide—leprosy	0.00242	0.00278	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Thalidomide—leprosy	0.0024	0.00276	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Thalidomide—leprosy	0.00232	0.00267	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Thalidomide—leprosy	0.00232	0.00267	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—tendon—leprosy	0.0023	0.0787	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—tendon—leprosy	0.00229	0.0782	CbGeAlD
Isosorbide Mononitrate—Hypersensitivity—Thalidomide—leprosy	0.00216	0.00249	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Thalidomide—leprosy	0.00211	0.00242	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Thalidomide—leprosy	0.00208	0.00239	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Thalidomide—leprosy	0.00201	0.00231	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Thalidomide—leprosy	0.00194	0.00223	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—testis—leprosy	0.00191	0.0652	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—testis—leprosy	0.00189	0.0647	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—nervous system—leprosy	0.00187	0.064	CbGeAlD
Isosorbide Mononitrate—Vomiting—Thalidomide—leprosy	0.00187	0.00215	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—nervous system—leprosy	0.00186	0.0635	CbGeAlD
Isosorbide Mononitrate—Rash—Thalidomide—leprosy	0.00185	0.00213	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Thalidomide—leprosy	0.00185	0.00213	CcSEcCtD
Isosorbide Mononitrate—Headache—Thalidomide—leprosy	0.00184	0.00211	CcSEcCtD
Isosorbide Mononitrate—Nausea—Thalidomide—leprosy	0.00174	0.00201	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—nervous system—leprosy	0.000535	0.0183	CbGeAlD
